Unraveling the differential mechanisms of revascularization promoted by MSCs & ECFCs from adipose tissue or umbilical cord in a murine model of critical limb-threatening ischemia.

Autor: Rojas-Torres M; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Cadiz, 11002, Spain.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), Cadiz, 11002, Spain., Beltrán-Camacho L; Cell Biology, Physiology and Immunology Department, University of Cordoba, Cordoba, 14004, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, 14004, Spain., Martínez-Val A; National Center of Cardiovascular Research Carlos III (CNIC), Madrid, 28029, Spain., Sánchez-Gomar I; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Cadiz, 11002, Spain.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), Cadiz, 11002, Spain., Eslava-Alcón S; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Cadiz, 11002, Spain.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), Cadiz, 11002, Spain., Rosal-Vela A; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Cadiz, 11002, Spain.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), Cadiz, 11002, Spain., Jiménez-Palomares M; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Cadiz, 11002, Spain.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), Cadiz, 11002, Spain., Doiz-Artázcoz E; Angiology & Vascular Surgery Unit, Hospital Universitario Puerta del Mar, Cadiz, Spain., Martínez-Torija M; Pathophysiology and Regenerative Medicine Group, Hospital Nacional de Parapléjicos (SESCAM), Toledo, 45071, Spain.; Nursing department, Hospital Universitario de Toledo (SESCAM), Toledo, 45071, Spain., Moreno-Luna R; Pathophysiology and Regenerative Medicine Group, Hospital Nacional de Parapléjicos (SESCAM), Toledo, 45071, Spain. rmluna@sescam.jccm.es.; Cooperative Research Network Orientated to Health Results, Vascular Brain Diseases, RICORS-ICTUS, SESCAM, Toledo, Spain. rmluna@sescam.jccm.es., Olsen JV; Novo Nordisk Foundation Center for Protein Research, Copenhagen, Denmark., Duran-Ruiz MC; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Cadiz, 11002, Spain. maricarmen.duran@gm.uca.es.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), Cadiz, 11002, Spain. maricarmen.duran@gm.uca.es.; Biomedicine, Biotechnology and Public Health Department, Science Faculty, Cádiz University. Torre Sur. Avda. República Saharaui S/N, Polígono Río San Pedro, Puerto Real, Cádiz, 11519, Spain. maricarmen.duran@gm.uca.es.

Publikováno v: Journal of biomedical science [J Biomed Sci] 2024 Jul 15; Vol. 31 (1), pp. 71. Date of Electronic Publication: 2024 Jul 15.

Cardiovascular-related proteomic changes in ECFCs exposed to the serum of COVID-19 patients.

Autor: Beltrán-Camacho L; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, 11002 Cadiz, Spain.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), 11002 Cadiz, Spain., Bhosale SD; Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense, Denmark., Sánchez-Morillo D; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, 11002 Cadiz, Spain.; Automation Engineering, Electronics and Computer Architecture and Networks Department, University of Cadiz, 11009 Cadiz, Spain., Sánchez-Gomar I; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, 11002 Cadiz, Spain.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), 11002 Cadiz, Spain., Rojas-Torres M; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, 11002 Cadiz, Spain.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), 11002 Cadiz, Spain., Eslava-Alcón S; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, 11002 Cadiz, Spain.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), 11002 Cadiz, Spain., Martínez-Torija M; Department of Nursing, National Paraplegic Hospital, Toledo, Spain., de Infante MAR; Occupational Health Service, National Paraplegic Hospital, SESCAM, 45071, Toledo, Spain., Nieto-Martín MD; Internal Medicine Department, University Hospital Virgen del Rocío, Seville, Spain., Rodríguez-Iglesias MA; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, 11002 Cadiz, Spain.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), 11002 Cadiz, Spain.; UGC Microbiología, University Hospital Puerta del Mar, Avda. Ana de Viya 21, 11009, Cádiz, Spain., Moreno JA; Cell Biology, Physiology and Immunology Department, Agrifood Campus of International Excellence (ceiA3), University of Cordoba, 14014, Córdoba, Spain.; Maimonides Biomedical Research Institute of Cordoba (IMIBIC), UGC Nephrology, Hospital Universitario Reina Sofia, 14004, Cordoba, Spain., Berrocoso E; Biomedical Research and Innovation Institute of Cadiz (INiBICA), 11002 Cadiz, Spain.; Psychology Department, University of Cádiz, 11510, Puerto Real, Spain.; Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Institute of Health Carlos III, 28029, Madrid, Spain., Larsen MR; Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense, Denmark., Moreno-Luna R; Laboratory of Neuroinflammation, National Paraplegic Hospital, 45071 Toledo, Spain.; Redes de investigación cooperativa orientadas a resultados en salud, Enfermedades vasculares cerebrales, RICORS-ICTUS, SESCAM., Durán-Ruiz MC; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, 11002 Cadiz, Spain.; Biomedical Research and Innovation Institute of Cadiz (INiBICA), 11002 Cadiz, Spain.

Publikováno v: International journal of biological sciences [Int J Biol Sci] 2023 Mar 05; Vol. 19 (6), pp. 1664-1680. Date of Electronic Publication: 2023 Mar 05 (Print Publication: 2023).

Assessment of endothelial colony forming cells delivery routes in a murine model of critical limb threatening ischemia using an optimized cell tracking approach.

Autor: Rojas-Torres M; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), Cádiz, Spain., Sánchez-Gomar I; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), Cádiz, Spain., Rosal-Vela A; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), Cádiz, Spain., Beltrán-Camacho L; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), Cádiz, Spain., Eslava-Alcón S; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), Cádiz, Spain., Alonso-Piñeiro JÁ; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), Cádiz, Spain., Martín-Ramírez J; Preclinical R&D Department at Ixaka Iberia SL, Seville, Spain., Moreno-Luna R; Laboratory of Neuroinflammation, Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain., Durán-Ruiz MC; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain. maricarmen.duran@gm.uca.es.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), Cádiz, Spain. maricarmen.duran@gm.uca.es.

Publikováno v: Stem cell research & therapy [Stem Cell Res Ther] 2022 Jun 21; Vol. 13 (1), pp. 266. Date of Electronic Publication: 2022 Jun 21.

Long Term Response to Circulating Angiogenic Cells, Unstimulated or Atherosclerotic Pre-Conditioned, in Critical Limb Ischemic Mice.

Autor: Beltrán-Camacho L; Biomedicine, Biotechnology and Public Health Department, Cadiz University, 11002 Cadiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), 11009 Cádiz, Spain., Jiménez-Palomares M; Biomedicine, Biotechnology and Public Health Department, Cadiz University, 11002 Cadiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), 11009 Cádiz, Spain., Sanchez-Gomar I; Biomedicine, Biotechnology and Public Health Department, Cadiz University, 11002 Cadiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), 11009 Cádiz, Spain., Rosal-Vela A; Biomedicine, Biotechnology and Public Health Department, Cadiz University, 11002 Cadiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), 11009 Cádiz, Spain., Rojas-Torres M; Biomedicine, Biotechnology and Public Health Department, Cadiz University, 11002 Cadiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), 11009 Cádiz, Spain., Eslava-Alcon S; Biomedicine, Biotechnology and Public Health Department, Cadiz University, 11002 Cadiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), 11009 Cádiz, Spain., Alonso-Piñero JA; Biomedicine, Biotechnology and Public Health Department, Cadiz University, 11002 Cadiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), 11009 Cádiz, Spain., González-Rovira A; Biomedicine, Biotechnology and Public Health Department, Cadiz University, 11002 Cadiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), 11009 Cádiz, Spain., Extremera-García MJ; Biomedicine, Biotechnology and Public Health Department, Cadiz University, 11002 Cadiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), 11009 Cádiz, Spain., Conejero R; Angiology & Vascular Surgery Unit, Hospital Universitario Puerta del Mar, 11009 Cádiz, Spain., Doiz E; Angiology & Vascular Surgery Unit, Hospital Universitario Puerta del Mar, 11009 Cádiz, Spain., Rodriguez-Piñero M; Angiology & Vascular Surgery Unit, Hospital Universitario Puerta del Mar, 11009 Cádiz, Spain., Larsen MR; Department of Biochemistry and Molecular Biology, University of Southern Denmark, 5230 Odense, Denmark., Duran-Ruiz MC; Biomedicine, Biotechnology and Public Health Department, Cadiz University, 11002 Cadiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cádiz (INiBICA), 11009 Cádiz, Spain.

Publikováno v: Biomedicines [Biomedicines] 2021 Sep 03; Vol. 9 (9). Date of Electronic Publication: 2021 Sep 03.

REX-001, a BM-MNC Enriched Solution, Induces Revascularization of Ischemic Tissues in a Murine Model of Chronic Limb-Threatening Ischemia.

Autor: Rojas-Torres M; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cadiz (INIBICA), Cádiz, Spain., Jiménez-Palomares M; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cadiz (INIBICA), Cádiz, Spain., Martín-Ramírez J; R&D Department at Rexgenero Biosciences Sociedad Limitada (SL), Seville, Spain., Beltrán-Camacho L; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cadiz (INIBICA), Cádiz, Spain., Sánchez-Gomar I; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cadiz (INIBICA), Cádiz, Spain., Eslava-Alcon S; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cadiz (INIBICA), Cádiz, Spain., Rosal-Vela A; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cadiz (INIBICA), Cádiz, Spain., Gavaldá S; R&D Department at Rexgenero Biosciences Sociedad Limitada (SL), Seville, Spain., Durán-Ruiz MC; Biomedicine, Biotechnology and Public Health Department, Cádiz University, Cádiz, Spain.; Institute of Research and Innovation in Biomedical Sciences of Cadiz (INIBICA), Cádiz, Spain.

Publikováno v: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2020 Dec 09; Vol. 8, pp. 602837. Date of Electronic Publication: 2020 Dec 09 (Print Publication: 2020).